Please Wait.....
Report
MEA Travel Vaccine Market - Industry Trends and Forecast to 2034
Market Report I 2024-03-01 I 250 Pages I Data Bridge Market Research
Middle East and Africa travel vaccine market is expected to reach USD 1,210,595.40 thousand by 2032 from USD 646,979.92 thousand in 2023, growing at a substantial CAGR of 7.4% in the forecast period of 2024 to 2032.
Market Segmentation:
Middle East and Africa travel vaccines market, By Composition (Combination Vaccines and Mono Vaccines), Type (Inactivated Vaccines, Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, Live-Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines, and Viral Vector Vaccines), Category (Recommended Vaccine, Routine Vaccine and Required Vaccine), Disease (Typhoid, Hepatitis, Cholera, Varicella, Influenza, Japanese Encephalitis, Meningococcal Meningitis, Yellow Fever, Rabies, DPT, Measles and Mumps, Tick-Borne Encephalitis, Malaria, Covid-19, Polio and Others), Route of Administration (Injectable and Oral), Gender (Male and Female), Patient Type (Adult, Pediatric and Geriatric), Age Group (20-50 Years, Less than 20 Years and Above 50 Years), Distribution Channel (B2B and B2C), Countries (Saudi Arabia, U.A.E., Israel, South Africa, Egypt, Kuwait, and Rest of Middle East and Africa) , Industry Trends and Forecast to 2032
Some of the major factors contributing to the growth of the Middle East and Africa travel vaccines market are:
Driver
- Rising incidence of infectious diseases
Restraint
- High cost of travel vaccines
Opportunity
- Advancements in vaccine technology
Market Players
Some major companies dealing in the Middle East and Africa travel vaccines market are:
- GSK plc.
- Pfizer Inc.
- Abbott
- CSL
- AstraZeneca
- Sanofi
- Merck & Co., Inc.
- Johnson & Johnson Services Inc.
- Dynavax Technologies.
TABLE OF CONTENTS
1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA TRAVEL VACCINES MARKET 49
1.4 LIMITATIONS 51
1.5 MARKETS COVERED 51
2 MARKET SEGMENTATION 55
2.1 MARKETS COVERED 55
2.2 GEOGRAPHICAL SCOPE 56
2.3 YEARS CONSIDERED FOR THE STUDY 57
2.4 CURRENCY AND PRICING 57
2.5 DBMR TRIPOD DATA VALIDATION MODEL 58
2.6 MULTIVARIATE MODELLING 61
2.7 PRODUCT TYPE LIFELINE CURVE 61
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 62
2.9 DBMR MARKET POSITION GRID 63
2.10 MARKET APPLICATION COVERAGE GRID 64
2.11 VENDOR SHARE ANALYSIS 65
2.12 SECONDARY SOURCES 66
2.13 ASSUMPTIONS 66
3 EXECUTIVE SUMMARY 67
4 PREMIUM INSIGHTS 70
4.1 PESTEL ANALYSIS 71
4.2 PORTER'S FIVE FORCES 72
4.3 PIPELINE ANALYSIS 73
5 MARKET OVERVIEW 77
5.1 DRIVERS 79
5.1.1 RISING INCIDENCE OF INFECTIOUS DISEASES 79
5.1.2 INCREASING TRAVEL AND TOURISM 81
5.1.3 GOVERNMENT REGULATIONS AND RECOMMENDATIONS REGARDING VACCINATION 82
5.1.4 EXPANSION OF TRAVEL MEDICINE CLINICS 82
5.2 RESTRAINTS 83
5.2.1 HIGH COST OF TRAVEL VACCINES 83
5.2.2 REGULATORY HURDLES FOR APPROVAL 84
?
5.3 OPPORTUNITIES 84
5.3.1 ADVANCEMENTS IN VACCINE TECHNOLOGY 84
5.3.2 GROWING AWARENESS REGARDING VACCINES 85
5.3.3 INTEGRATION OF DIGITAL HEALTH SOLUTIONS 85
5.4 CHALLENGES 86
5.4.1 COLD CHAIN REQUIREMENTS FOR STORAGE 86
5.4.2 VACCINE HESITANCY AND MISINFORMATION 87
6 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY COMPOSITION 88
6.1 OVERVIEW 89
6.2 COMBINATION VACCINES 92
6.3 MONO VACCINES 92
7 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY TYPE 93
7.1 OVERVIEW 94
7.2 INACTIVATED VACCINES 97
7.2.1 HEPATITIS A 98
7.2.2 INFLUENZA 98
7.2.3 RABIES 98
7.2.4 TICK-BORNE ENCEPHALITIS 98
7.2.5 JAPANESE ENCEPHALITIS 98
7.2.6 POLIO 99
7.3 SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES 99
7.3.1 HEPATITIS B 100
7.3.2 MENINGOCOCCAL 100
7.3.3 MALARIA 100
7.3.4 COVID-19 100
7.4 LIVE-ATTENUATED VACCINES 101
7.4.1 TYPHOID 102
7.4.2 CHOLERA 102
7.4.3 YELLOW FEVER 102
7.4.4 MEASLES 102
7.4.5 MUMPS 103
7.4.6 RUBELLA 103
7.4.7 VARICELLA 103
7.4.8 OTHERS 103
7.5 TOXOID VACCINES 103
7.5.1 DIPHTHERIA 104
7.5.2 TETANUS 104
7.6 DNA VACCINES 104
?
7.7 VIRAL VECTOR VACCINES 105
8 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY CATEGORY 106
8.1 OVERVIEW 107
8.2 RECOMMENDED VACCINE 110
8.2.1 TYPHOID FEVER VACCINES 111
8.2.2 HEPATITIS A 111
8.2.3 CHOLERA 111
8.2.4 RABIES 111
8.2.5 TICK-BORNE ENCEPHALITIS 111
8.2.6 JAPANESE ENCEPHALITIS 111
8.2.7 MALARIA 111
8.2.8 OTHERS 111
8.3 ROUTINE VACCINE 112
8.3.1 HEPATITIS B 113
8.3.2 INFLUENZA VACCINES 113
8.3.3 PNEUMOCOCCAL 113
8.3.4 DIPHTHERIA 113
8.3.5 TETANUS 113
8.3.6 MEASLES 113
8.3.7 MUMPS 113
8.3.8 RUBELLA 113
8.3.9 PERTUSSIS 113
8.3.10 OTHERS 114
8.4 REQUIRED VACCINE 114
8.4.1 YELLOW FEVER 115
8.4.2 MENINGOCOCCAL 115
8.4.3 POLIO VACCINES 115
9 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY DISEASE 116
9.1 OVERVIEW 117
9.2 TYPHOID 121
9.3 HEPATITIS 121
9.3.1 HEPATITIS A 122
9.3.2 HEPATITIS B 122
9.4 CHOLERA 122
9.5 VARICELLA 123
9.6 INFLUENZA 123
9.7 JAPANESE ENCEPHALITIS 124
9.8 MENINGOCOCCAL MENINGITIS 124
9.9 YELLOW FEVER 125
9.10 RABIES 125
9.11 DPT 126
9.12 MEASLES AND MUMPS 126
9.13 TICK-BORNE ENCEPHALITIS 127
9.14 MALARIA 127
9.15 COVID-19 128
9.16 POLIO 128
9.17 OTHERS 129
10 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION 130
10.1 OVERVIEW 131
10.2 INJECTABLE 134
10.2.1 INTRAMUSCULAR 135
10.2.2 SUBCUTANEOUS 135
10.2.3 OTHERS 135
10.3 ORAL 135
11 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY GENDER 136
11.1 OVERVIEW 137
11.2 MALE 140
11.3 FEMALE 140
12 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY PATIENT TYPE 141
12.1 OVERVIEW 142
12.2 ADULT 145
12.3 PEDIATRIC 145
12.4 GERIATRIC 146
13 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY AGE GROUP 147
13.1 OVERVIEW 148
13.2 20-50 YEARS 151
13.3 LESS THAN 20 YEARS 152
13.4 ABOVE 50 YEARS 153
14 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL 154
14.1 OVERVIEW 155
14.2 B2B 158
14.3 B2C 158
?
15 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET, BY REGION 159
15.1 MIDDLE EAST AND AFRICA 162
15.1.1 SAUDI ARABIA 170
15.1.2 EGYPT 176
15.1.3 SOUTH AFRICA 182
15.1.4 KUWAIT 187
15.1.5 U.A.E. 192
15.1.6 ISRAEL 198
15.1.7 REST OF MIDDLE EAST AND AFRICA 203
16 MIDDLE EAST AND AFRICA TRAVEL VACCINE MARKET: COMPANY LANDSCAPE 204
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
17 SWOT ANALYSIS 205
18 COMPANY PROFILE 206
18.1 PFIZER INC. 206
18.1.1 COMPANY SNAPSHOT 206
18.1.2 REVENUE ANALYSIS 206
18.1.3 COMPANY SHARE ANALYSIS 207
18.1.4 PRODUCT PORTFOLIO 207
18.1.5 RECENT DEVELOPMENT 208
18.2 SANOFI 209
18.2.1 COMPANY SNAPSHOT 209
18.2.2 REVENUE ANALYSIS 209
18.2.3 COMPANY SHARE ANALYSIS 210
18.2.4 PRODUCT PORTFOLIO 210
18.2.5 RECENT DEVELOPMENT 214
18.3 JOHNSON & JOHNSON SERVICES INC. 215
18.3.1 COMPANY SNAPSHOT 215
18.3.2 REVENUE ANALYSIS 215
18.3.3 COMPANY SHARE ANALYSIS 216
18.3.4 PRODUCT PORTFOLIO 216
18.3.5 RECENT DEVELOPMENTS 217
18.4 GSK PLC. 218
18.4.1 COMPANY SNAPSHOT 218
18.4.2 REVENUE ANALYSIS 218
18.4.3 COMPANY SHARE ANALYSIS 219
18.4.4 PRODUCT PORTFOLIO 219
18.4.5 RECENT DEVELOPMENT 224
?
18.5 MERCK & CO., INC. 226
18.5.1 COMPANY SNAPSHOT 226
18.5.2 REVENUE ANALYSIS 226
18.5.3 COMPANY SHARE ANALYSIS 227
18.5.4 PRODUCT PORTFOLIO 227
18.5.5 RECENT DEVELOPMENT 229
18.6 ABBOTT 230
18.6.1 COMPANY SNAPSHOT 230
18.6.2 REVENUE ANALYSIS 230
18.6.3 PRODUCT PORTFOLIO 231
18.6.4 RECENT DEVELOPMENT 232
18.7 ASTRAZENECA 233
18.7.1 COMPANY SNAPSHOT 233
18.7.2 REVENUE ANALYSIS 233
18.7.3 PRODUCT PORTFOLIO 234
18.7.4 RECENT DEVELOPMENT 234
18.8 BAVARIAN NORDIC 236
18.8.1 COMPANY SNAPSHOT 236
18.8.2 REVENUE ANALYSIS 236
18.8.3 PRODUCT PORTFOLIO 237
18.8.4 RECENT DEVELOPMENT 237
18.9 CSL 239
18.9.1 COMPANY SNAPSHOT 239
18.9.2 REVENUE ANALYSIS 239
18.9.3 PRODUCT PORTFOLIO 240
18.9.4 RECENT DEVELOPMENT 241
18.10 DYNAVAX TECHNOLOGIES. 242
18.10.1 COMPANY SNAPSHOT 242
18.10.2 REVENUE ANALYSIS 242
18.10.3 PRODUCT PORTFOLIO 243
18.10.4 RECENT DEVELOPMENTS 243
18.11 VALNEVA SE 244
18.11.1 COMPANY SNAPSHOT 244
18.11.2 REVENUE ANALYSIS 244
18.11.3 PRODUCT PORTFOLIO 245
18.11.4 RECENT DEVELOPMENT 245
19 QUESTIONNAIRE 246
20 RELATED REPORTS 250
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security